Guardant Health, Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
-37,79
Forward P/E Ratio
-229,29
PEG Ratio
-3,64
-44,70
Price-to-Sales (TTM)
16,33
-90,96
-1,38
Market Cap
16,66B
18,25B
Is it profitable?
Net Profit Margin (TTM)
-40,10%
Gross Profit Margin
65,22%
Diluted EPS (TTM)
-3,41
419,18%
1,08B
Is it growing?
48,30%
48,26%
Is it risky?
1,49
-9,41
4,68
1,70B
Who owns it?
105,77%
4,03%
10,17%
131,51M
127,81M
Does it pay?
0,00%
0,00%
--
--
How much cash?
1,10B
-187,69M
-85,45M
8,32
- Price
- 125,61
- Percent Change
- -7,45 (5,60%)
- Previous Close
- 133,06
- Open
- 132,63
- Low
- 124,97
- High
- 133,34
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$125,61
From 52W Low
+211.30%
From 52W High
-6.46%
Today
-5.60%
1Y Change
+161.36%
6M
$104,17
3M
$91,20
1M
$92,25
Today
$125,61
From 52W Low
+211.30%
From 52W High
-6.46%
Today
-5.60%
1Y Change
+161.36%
6M
$104,17
3M
$91,20
1M
$92,25
Today
$125,61
Expensive
within its 1-year price range
$125,61
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+36.2%
3M
+37.7%
6M
+20.6%
1Y
+161.4%
Rate of Change (ROC)
Accelerating
Price is rising 3.7x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Guardant Health, Inc.
- Founded
- 2011
- CEO
- Helmy Eltoukhy
- Employees
- 2.490
- Fiscal Year End
- Dec 31, 2024
- Address
505 Penobscot Drive
Redwood City
California
94063
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.guardanthealth.com
Indicators
Operating Cash Flow
-187,69M
Net Income
-433,19M
Paper Profits
0.43
Company reports significant profit, but very little cash is actually coming in. This pattern has historically preceded earnings corrections and dividend cuts.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
-187,69M
Net Income
-433,19M
Paper Profits
0.43
Company reports significant profit, but very little cash is actually coming in. This pattern has historically preceded earnings corrections and dividend cuts.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
-37,79
Forward P/E Ratio
-229,29
PEG Ratio
-3,64
-44,70
Price-to-Sales (TTM)
16,33
-90,96
-1,38
Market Cap
16,66B
18,25B
Is it profitable?
Net Profit Margin (TTM)
-40,10%
Gross Profit Margin
65,22%
Diluted EPS (TTM)
-3,41
419,18%
1,08B
Is it growing?
48,30%
48,26%
Is it risky?
1,49
-9,41
4,68
1,70B
Who owns it?
105,77%
4,03%
10,17%
131,51M
127,81M
Does it pay?
0,00%
0,00%
--
--
How much cash?
1,10B
-187,69M
-85,45M
8,32
- Price
- 125,61
- Percent Change
- -7,45 (5,60%)
- Previous Close
- 133,06
- Open
- 132,63
- Low
- 124,97
- High
- 133,34
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$125,61
From 52W Low
+211.30%
From 52W High
-6.46%
Today
-5.60%
1Y Change
+161.36%
6M
$104,17
3M
$91,20
1M
$92,25
Today
$125,61
From 52W Low
+211.30%
From 52W High
-6.46%
Today
-5.60%
1Y Change
+161.36%
6M
$104,17
3M
$91,20
1M
$92,25
Today
$125,61
Expensive
within its 1-year price range
$125,61
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+36.2%
3M
+37.7%
6M
+20.6%
1Y
+161.4%
Rate of Change (ROC)
Accelerating
Price is rising 3.7x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Guardant Health, Inc.
- Founded
- 2011
- CEO
- Helmy Eltoukhy
- Employees
- 2.490
- Fiscal Year End
- Dec 31, 2024
- Address
505 Penobscot Drive
Redwood City
California
94063
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.guardanthealth.com